Myriad Genetics Inc (NAS:MYGN)
$ 26.835 0.445 (1.69%) Market Cap: 2.44 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 3.29 GF Score: 78/100

Myriad Genetics Inc at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 10:00PM GMT
Release Date Price: $17.99 (-1.80%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Good afternoon, everyone. I'm Derik De Bruin, the senior life sciences and diagnostics analyst here at Bank of America. Welcome to our 2023 Healthcare Conference and coming to you live from the Encore here in fabulous Las Vegas. It's my great pleasure to welcome Myriad Genetics and Paul Diaz, President and CEO of the company. Paul, thank you for being here.

Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director

Thank you, Derik. Appreciate the opportunity.

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

So I have a long history with Myriad. I have covered their stock in some form since 2001.

Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director

We're quite a different organization these days.

Questions & Answers

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot